Drug profile · INN
phenoxybenzamine hydrochloride
PHENOXYBENZAMINE HYDROCHLORIDE
phenoxybenzamine hydrochloride (PHENOXYBENZAMINE HYDROCHLORIDE) is a adrenergic receptor alpha antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — phenoxybenzamine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
phenoxybenzamine hydrochloride (PHENOXYBENZAMINE HYDROCHLORIDE) is a adrenergic receptor alpha antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha antagonist
Primary target: Adrenergic receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is phenoxybenzamine hydrochloride?
phenoxybenzamine hydrochloride (PHENOXYBENZAMINE HYDROCHLORIDE) is a adrenergic receptor alpha antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for phenoxybenzamine hydrochloride?
PHENOXYBENZAMINE HYDROCHLORIDE is a marketed brand name for phenoxybenzamine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of phenoxybenzamine hydrochloride?
phenoxybenzamine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.